Kepler Cheuvreux Suisse SA Sells 72,420 Shares of Stryker Corporation $SYK

Kepler Cheuvreux Suisse SA trimmed its position in shares of Stryker Corporation (NYSE:SYK) by 95.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,201 shares of the medical technology company’s stock after selling 72,420 shares during the quarter. Kepler Cheuvreux Suisse SA’s holdings in Stryker were worth $1,125,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of SYK. United Financial Planning Group LLC purchased a new position in Stryker during the third quarter worth $27,000. CGC Financial Services LLC purchased a new position in Stryker during the fourth quarter worth $29,000. Strive Asset Management LLC purchased a new position in Stryker during the third quarter worth $30,000. ANTIPODES PARTNERS Ltd purchased a new position in Stryker during the third quarter worth $34,000. Finally, Copia Wealth Management boosted its stake in Stryker by 181.6% during the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock worth $40,000 after buying an additional 69 shares during the period. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. Robert W. Baird set a $385.00 price target on Stryker in a research note on Friday, May 1st. BTIG Research decreased their price target on Stryker from $397.00 to $379.00 and set a “buy” rating for the company in a research note on Friday, May 1st. TD Cowen lowered Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target for the company. in a research note on Monday, January 26th. Needham & Company LLC decreased their price target on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Finally, Citigroup decreased their price target on Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research note on Tuesday, April 7th. Sixteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Stryker Trading Down 0.9%

Shares of NYSE SYK opened at $282.85 on Tuesday. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The business has a fifty day simple moving average of $336.33 and a two-hundred day simple moving average of $353.81. The firm has a market cap of $108.33 billion, a PE ratio of 32.74, a price-to-earnings-growth ratio of 1.80 and a beta of 0.80. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $404.87.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period last year, the firm earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Analysts expect that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s payout ratio is 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.